Safety and efficacy of bortezomib‐based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMAFortunato Morabito, Michèle Cavo, Sara Galimberti et al.|European Journal Of Haematology|2009Cited by 81
Bortezomib (VEL) Based Regimens in Multiple Myeloma (MM) Patients with Renal Impairment (RI): A Preliminary Retrospective Italian Multicenter StudyMassimo Gentile, Fortunato Morabito, Stefania Ciolli et al.|Blood|2008Cited by 2